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ardiac hypertrophy is an adaptive response of the heart to persistent increases in hemodynamic workload, such as those caused by hypertension. Although this process is beneficial in terms of normalizing wall stress and oxygen consumption, sustained left ventricular hypertrophy significantly increases the risk of heart failure and sudden death. 1 Inflammatory cytokines play an important role in the progression of cardiac hypertrophy 2 ; low cytokine levels may be protective for myocytes, whereas persistently high levels are detrimental. 3, 4 The efferent arm of the vagus nerve can exert anti-inflammatory effects through the α7-nicotinic acetylcholine receptors that are expressed on central nervous system-specific cells and immune cells, including macrophages and CD4 + T cells. 5, 6 The binding of acetylcholine to α7-nicotinic acetylcholine receptors attenuates the human macrophage production of inflammatory cytokines, such as interleukin (IL)-6, IL-1β, IL-18, and tumor necrosis factor (TNF)-α. 7 Stimulation of the vagus nerve by nicotine, a specific α7-nicotinic acetylcholine receptor agonist, has been shown to reduce IL-6 and TNF-α production in sepsis and to reduce inflammatory cell infiltration in a carrageenan air pouch model. 8, 9 In addition, nicotine-induced reductions in cytokine concentrations have been shown to effectively reduce the incidence of diabetes mellitus in mice, 10 attenuate the severity of ulcerative colitis, 11 and relieve cardiac hypertrophy in autoimmune myocarditis. 12 These effects are produced through what is referred to as the cholinergic anti-inflammatory pathway. 13 In hypertension models of varying causes, a deficit in the cholinergic antiinflammatory pathway contributes to cardiac hypertrophy, and α7nAChR activation relieves the hypertrophy.
reports, ghrelin has a cardiovascular role whereby it prevents malignant arrhythmia, improves heart function, and attenuates cardiac remodeling after myocardial infarction. 17 Ghrelin's mechanism of action seems to be related to the modulation of the autonomic nervous system. Besides suppressing the activation of cardiac sympathetic nerve activity, ghrelin is also apparently able to activate the efferent arm of the vagus nerve in the heart and gastrointestinal tract. [18] [19] [20] [21] Although ghrelin can theoretically act on the cholinergic anti-inflammatory pathway and therefore be involved in cardiac hypertrophy, this possibility has yet to be fully investigated. We therefore aimed to determine the effects of endogenous ghrelin on cardiac hypertrophy and to assess the contribution of the cholinergic anti-inflammatory pathway by using a pressure overload-induced cardiac hypertrophy model in ghrelin knockout mice. 
Methods
A detailed description of Methods is available in the online Data Supplement.
Administration of Nicotine, Ghrelin, and Methylatropine
First, (−)-nicotine hydrogen tartrate salt (Sigma-Aldrich Corporation, St. Louis, MO) was dissolved in drinking water at a concentration of 125 mg/L and administered orally (≈16 mg/kg per day) from 3 days before the operation until the end of observation.
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Ghrelin was administered by a subcutaneous bolus injection to the neck (1.2 mg/kg per day, equivalent to ≈400 nmol/kg per day) 30 minutes before the surgical procedure and was continuously administered until the end of observation. The dose of ghrelin was selected to generate blood levels in excess of physiological concentrations for >16 hours after injection in gastrectomized mice. 22 In cases of methylatropine bromide (1 mg/kg) administration, it was injected intraperitoneally 5 minutes after the ghrelin injection. 23 
Statistical Analysis
Heart rate variability and hemodynamics were expressed as mean±SEM; other values were expressed as means±SD. Statistical analysis was performed using Prism version 4 (GraphPad Software Inc, San Diego, CA). The significance of differences observed between groups of mice was analyzed using a 1-way ANOVA followed by the Tukey post hoc test for multiple comparisons. The minimum probability value that was considered significant was 0.05.
Results

Augmented Cardiac Hypertrophy in Ghrelin Knockout Mice
The baseline characteristics of the knockout and wild-type (WT) genotypes are shown in Table S1 in the online-only Data Supplement. When comparing measurements taken before and 12 weeks after the operation, no significant differences were found between the groups with respect to body weight (BW), tibial length (TL), heart rate, and systolic and diastolic blood pressures. However, postoperative BW in the transverse aortic constriction (TAC) groups did not increase in the same manner as it did in the sham-operated (Sham) groups (a tendency toward increase versus the preoperative BW) or the TAC groups that received ghrelin or nicotine (significant increase versus the preoperative BW).
In the TAC groups, the ascending aortic systolic pressure and the left ventricular systolic pressure were 50 to 60 mm Hg higher than the Sham group values (P<0.05; Figure 1A and 1B). No differences were found among the TAC groups. Because only moderate pressure overload was introduced in these mice, no between-group differences were observed in the hemodynamic study with respect to parameters representing systolic function, such as left ventricular ejection fraction and end-systolic elastance (Table S2 ). However, 12 weeks after TAC, diastolic function in knockout mice was reduced compared with that of WT mice, as evidenced by the slope of the end-diastolic pressurevolume relationship and the τ-index (Table S2) .
To evaluate cardiac hypertrophy, we compared heart weights (HWs) at 2 and 12 weeks postoperatively; TL was used as the adjustment factor because BW and growth tendencies were found to depend on whether a TAC or sham operation was performed. Typical heart samples from each group are shown in Figure 1C . Although HW/TL ratios did not differ between the 2 Sham groups, in the TAC groups, knockout mice showed significantly higher HW/TL ratios than WT mice at both 2 and 12 weeks after TAC (P<0.05; Figure 1D ). Meanwhile, no between-group differences were observed in lung weight/TL ratios (data not shown).
In addition, echocardiographic examinations were performed 2 and 12 weeks after the TAC or sham operation (Figure 2 ). In the Sham groups, knockout mice and WT mice had nearly the same left ventricular anterior wall thickness and posterior wall thickness. In the TAC groups, however, the left ventricular anterior wall thickness and posterior wall thickness were significantly greater in knockout mice than in WT mice 12 weeks after TAC (P<0.05).
Inhibited Cholinergic Anti-Inflammatory Pathway in Ghrelin Knockout Mice
Plasma IL-1β, IL-6, and TNF-α levels were determined at 2 days, 2 weeks, and 12 weeks after the operation (Figure 3) . After TAC, IL-1β and IL-6 levels were significantly higher in knockout mice than in WT mice at every time point (P<0.05); TNF-α could not be detected in any group (data not shown).
Heart rate variability in knockout and WT mice was examined at 2 days, 2 weeks, and 12 weeks postoperatively. These data were then used to separately investigate the cardiac autonomic activity of the sympathetic and parasympathetic nerves in rodents. Specifically, the ratio of low-frequency power/ high-frequency power (HF) was used to represent relative cardiac sympathetic nerve activity, whereas HF represented absolute parasympathetic nerve activity. 24, 25 Although there was no significant difference in low-frequency power/HF and HF between the 2 genotypes after the sham operation, knockout mice had significantly lower parasympathetic nerve activity than WT mice at 2 and 12 weeks after TAC (Figure 4) .
Ghrelin or Nicotine Administration Activates the Cholinergic Anti-Inflammatory Pathway and Attenuates Cardiac Hypertrophy in Ghrelin Knockout Mice
Ghrelin administration was shown to significantly reduce IL-6 levels in knockout mice 2 days after TAC, but this effect was blocked by the coinjection of methylatropine bromide ( Figure  S1A ). Nicotine was able to reduce both IL-6 and IL-1β levels in knockout TAC mice at 2 days postoperatively ( Figure S1B ).
When the duration of nicotine or ghrelin administration was extended to 12 weeks postoperatively, both were found to significantly activate the cholinergic anti-inflammatory pathway ( Figure 5A and 5B). Parasympathetic nerve activity (as represented by HF) was activated in the knockout TAC group that received ghrelin or nicotine. Ghrelin or nicotine administration also completely suppressed the increases in IL-1β and IL-6 levels in knockout TAC mice (P<0.05).
Nicotine or ghrelin administration into knockout mice significantly attenuated cardiac hypertrophy as indicated by the HW/TL ratio and left ventricular anterior wall thickness, whereas left ventricular posterior wall thickness was only significantly attenuated in the knockout TAC group that received nicotine (P<0.05; Figure 5C and 5D).
Diastolic heart function in knockout TAC mice was inferior to that of WT TAC mice, as evidenced by the τ-index and slope of the end-diastolic pressure-volume relationship. Nicotine or ghrelin administration significantly reduced these 2 parameters in knockout TAC mice (P<0.05; Table S2 ).
Discussion
By comparing knockout TAC mice with WT TAC mice in a pressure overload-induced cardiac hypertrophy model, we were able to show for the first time that the absence of endogenous ghrelin results in severe cardiac hypertrophy and an obvious deterioration in diastolic heart function. This was accompanied by inhibition of the cholinergic anti-inflammatory pathway, as indicated by decreased parasympathetic nerve activity and increased plasma proinflammatory cytokine IL-6 and IL-1β levels. Activation of the cholinergic anti-inflammatory pathway by the administration of nicotine or ghrelin suppresses the increases in IL-6 and IL-1β levels and dramatically improves cardiac hypertrophy and diastolic heart function in knockout TAC mice. The cardioprotective effects of ghrelin have been reported in previous studies. In mice with myocardial infarction, ghrelin administration attenuated a collagen volume fraction increase in the noninfarct region. 26 knockout mice were also shown to experience excessive post-myocardial infarction remodeling, as indicated by an enlarged chamber, an increase in left ventricular wall thickness and the HW/TL ratio, and a deterioration of systolic heart function. 27 The results of this study are consistent with those of previous studies and also demonstrate the importance of endogenous ghrelin in the progression of cardiac hypertrophy.
The elevated circulating IL-1β and IL-6 levels originate from activated immune and nonimmune cells in the pressureoverloaded hearts. 28 Elevated circulating cytokines play an important role in cardiac hypertrophy in both humans and animals. [28] [29] [30] [31] In a recent study, IL-6 infusion in rats caused cardiac hypertrophy and diastolic dysfunction and produced a myocardial phenotype identical to that of a hypertensive heart. 29 The concomitant overexpression of both IL-6 and the IL-6 receptor in mice induced concentric hypertrophy, 30 whereas the removal of IL-6 improves cardiac hypertrophy induced by angiotensin II infusion. 31 By contrast, pressure-mediated hypertrophy and mechanical stretch can generate a subinflammatory level of IL-1β that constitutively maintains an adaptable compensatory hypertrophy. 32 The ability of ghrelin to suppress inflammation has been demonstrated in numerous diseases, including sepsis, cerebral ischemia, and renal ischemia and reperfusion injury. [33] [34] [35] Under these conditions, ghrelin was shown to reduce plasma levels of proinflammatory cytokines, including IL-6 and TNF-α through activation of the vagus nerve. [33] [34] [35] Our study showed that the effects of endogenous ghrelin can be substituted for by nicotine administration and that the suppression of IL-6 by exogenous ghrelin was completely blocked by methylatropine coinjection, providing further evidence of the involvement of the cholinergic anti-inflammatory pathway.
Ghrelin modulation of the vagal efferent nerve has been well documented by previous studies. Centrally administered ghrelin stimulates pancreatic exocrine secretion through the vagal efferent nerve. 19 Circulating ghrelin also stimulates pancreatic secretion via a vagal cholinergic efferent pathway after gaining access to the brain stem vagovagal circuitry via the area postrema. 20 Using a microdialysis technique, centrally administered ghrelin was shown to activate the cardiac vagal nerve. 21 In addition, peripheral ghrelin was shown to have a moderate effect on parasympathetic nerve activity as represented by HF in healthy controls. 17 Vagotomized subjects did not respond to ghrelin, suggesting the importance of the vagus nerve to the effects of peripheral ghrelin. 18 In this study, knockout mice consistently showed suppressed parasympathetic nerve activity, as indicated by a low HF after TAC, and the suppressed parasympathetic nerves were activated by exogenous ghrelin.
The inhibition of sympathetic nerve activity may also be partially responsible for the effects of ghrelin on cardiac hypertrophy. Sympathetic nerve activity is important for the progress of cardiac hypertrophy, 36 and ghrelin has been shown to have sympathoinhibiting effects. 17 However, sympathoinhibition cannot fully explain ghrelin's cardioprotective effects. In our previous study, we found that although treatment with the β-blocker metoprolol could reverse post-myocardial infarction cardiac dysfunction in knockout mice, it failed to decrease the augmented gene expression of collagen I, collagen III, and fibronectin. 33 In this study, although there was a tendency toward higher relative sympathetic nerve activity (represented by a higher low-frequency power/HF ratio) in knockout mice than in WT mice after TAC, the difference in absolute parasympathetic nerve activity (represented by HF) was greater. Sympathetic nerves are commonly activated by systolic dysfunction to maintain cardiac output. 37 Therefore, it is possible that because no obvious systolic dysfunction was induced in our model, sympathetic nerves were not strongly activated and parasympathetic nerves played the major role.
However, other mechanisms, including a direct myocardial action of ghrelin, may also be involved in these cardioprotective effects. Moreover, previous studies using genetically modified mice revealed significant sex differences in cardiac phenotypes. 38 It would therefore be prudent to extend our results to the female sex.
Perspectives
The endocrine, nervous, and immune systems are the body's major adaptive systems and are involved in functionally relevant cross-talk to maintain homeostasis. However, the amount of research on the communication between these systems is insufficient. Our study suggests that endogenous ghrelin, a gut hormone, plays a crucial role in attenuating pressure overload-induced cardiac hypertrophy and diastolic dysfunction. These effects are likely due to the activation of the cholinergic anti-inflammatory pathway. By simultaneously evoking sympathetic inhibition and parasympathetic activation, ghrelin was shown to be effective against cardiovascular diseases. In each group, n=8. C, Ghre or Nico administration reduced left ventricular anterior wall thickness (LVAWth) and left ventricular posterior wall thickness (LVPWth) on echocardiography. In the wild-type (WT) transverse aortic constriction (TAC) group, n=15; in the KO TAC+Nico group, n=16; in other groups, n=9. D, Ghre or Nico administration attenuated the heart weight (HW)/tibial length (TL) ratio. In the WT TAC group, n=15; in the KO TAC+Nico group, n=16; in other groups, n=9. The data presented here are mean±SD (except in B, where mean±SEM was graphed). * indicates a significant difference when compared with the WT TAC group (P<0.05). # indicates a significant difference when compared with the KO TAC group (P<0.05). LF indicates low-frequency power. 
